Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aluminium glycinate
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Aluminium glycinate is an organo-metallic compound used primarily as an antacid. It acts by neutralizing excess gastric acid in the stomach and is indicated for the treatment of heartburn, indigestion, acid reflux, ulcers, and gas. The compound may also be used as a stabilizer or excipient in pharmaceutical formulations to improve solubility and absorption of active ingredients. Additionally, it finds applications in dietary supplements (as a bioavailable source of aluminum), food additives, cosmetics (for moisturizing properties), and agriculture (as a micronutrient fertilizer).
- Other names
- aluminio glicinatodihydroxyaluminum aminoacetate
Beyond the preview
Go deeper on aluminium glycinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aluminium glycinate.